4.2 Article

Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia

期刊

EXPERIMENTAL HEMATOLOGY
卷 93, 期 -, 页码 70-U53

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2020.11.002

关键词

-

资金

  1. U.S. National Institutes of Health [R37HL052725, P01HL048546]
  2. Leukemia and Lymphoma Society [6237-13]
  3. Fanconi Anemia Research Fund
  4. SEP-CONACYT [243102]
  5. PAPIIT [IA202615]

向作者/读者索取更多资源

Fanconi anemia (FA) is a chromosome instability syndrome with congenital abnormalities, cancer predisposition, and bone marrow failure (BMF). AVID200, a TGF beta 1- and TGF beta 3-specific inhibitor, shows promising effects on FA hematopoiesis, particularly in patients progressing to severe aplastic anemia or myelodysplastic syndrome (MDS). AVID200 downregulates NHEJ-related genes and reduces DNA damage in primary FA HSPCs, indicating its potential as a therapeutic approach for improving BMF in FA.
Fanconi anemia (FA) is a chromosome instability syndrome with congenital abnormalities, cancer predisposition and bone marrow failure (BMF). Although hematopoietic stem and progenitor cell (HSPC) transplantation is the recommended therapy, new therapies are needed for FA patients without suitable donors. BMF in FA is caused, at least in part, by a hyperactive growth-suppressive transforming growth factor beta (TGF beta) pathway, regulated by the TGF beta 1, TGF beta 2, and TGF beta 3 ligands. Accordingly, the TGF beta pathway is an attractive therapeutic target for FA. While inhibition of TGF beta 1 and TGF beta 3 promotes blood cell expansion, inhibition of TGF beta 2 is known to suppress hematopoiesis. Here, we report the effects of AVID200, a potent TGF beta 1- and TGF beta 3-specific inhibitor, on FA hematopoiesis. AVID200 promoted the survival of murine FA HSPCs in vitro. AVID200 also promoted in vitro the survival of human HSPCs from patients with FA, with the strongest effect in patients progressing to severe aplastic anemia or myelodysplastic syndrome (MDS). Previous studies have indicated that the toxic upregulation of the nonhomologous end-joining (NHEJ) pathway accounts, at least in part, for the poor growth of FA HSPCs. AVID200 downregulated the expression of NHEJ-related genes and reduced DNA damage in primary FA HSPC in vitro and in in vivo models. Collectively, AVID200 exhibits activity in FA mouse and human preclinical models. AVID200 may therefore provide a therapeutic approach to improving BMF in FA. (c) 2020 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Large-scale topological disruption of chromosome territories 9 and 22 is associated with nonresponse to treatment in CML

Eunice Fabian-Morales, David Vallejo-Escamilla, Adriana Gudino, Alfredo Rodriguez, Rodrigo Gonzalez-Barrios, Yameli L. Rodriguez Torres, Clementina Castro Hernandez, Alfredo H. Torre-Lujan, Diego A. Oliva-Rico, Erandhi C. Ornelas Guzman, Alejandro Lopez Saavedra, Sara Frias, Luis A. Herrera

Summary: Resistance to TKI in CML is correlated with high levels of structural disruption of CT9 and CT22 in CD34+ cells, increased CT volumes (especially for CT22), intermingling between CT9 and CT22, and an open-chromatin epigenetic mark in CT22. These findings could potentially serve as a prognostic marker of response to treatment in CML and provide insights into mechanisms of TKI resistance.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Biochemistry & Molecular Biology

Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG

Pedro Reyes, Benilde Garcia-de Teresa, Ulises Juarez, Fernando Perez-Villatoro, Moises O. Fiesco-Roa, Alfredo Rodriguez, Bertha Molina, Maria Teresa Villarreal-Molina, Jorge Melendez-Zajgla, Alessandra Carnevale, Leda Torres, Sara Frias

Summary: This study evaluated the characteristics of a novel founder FANCG PV found in three Fanconi anemia patients from the Mixe community of Oaxaca, Mexico. The patients showed chromosomal instability and a homozygous PV, and their phenotype varied in severity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

Rapid in vivo multiplexed editing (RIME) of the adult mouse liver

Takeshi Katsuda, Hector Cure, Jonathan Sussman, Kamen P. Simeonov, Christopher Krapp, Zoltan Arany, Markus Grompe, Ben Z. Stanger

Summary: This study introduces a rapid in vivo multiplexed editing (RIME) method that enables the efficient inactivation of one or more genes in the mouse liver. The method is quick, efficient, and cost-effective, making it a valuable tool for analyzing multiple genes in vivo.

HEPATOLOGY (2023)

Review Oncology

Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability

Moises O. Fiesco-Roa, Benilde Garcia-de Teresa, Paula Leal-Anaya, Renee van 't Hek, Talia Wegman-Ostrosky, Sara Frias, Alfredo Rodriguez

Summary: Inherited bone marrow failure syndromes are a group of complex genetic diseases associated with disrupted genome maintenance, leading to a variety of clinical manifestations. These diseases require high index of suspicion and should be considered even in the absence of obvious clinical manifestations.

FRONTIERS IN ONCOLOGY (2022)

Article Multidisciplinary Sciences

A DNA methylation atlas of normal human cell types

Netanel Loyfer, Judith Magenheim, Ayelet Peretz, Gordon Cann, Joerg Bredno, Agnes Klochendler, Ilana Fox-Fisher, Sapir Shabi-Porat, Merav Hecht, Tsuria Pelet, Joshua Moss, Zeina Drawshy, Hamed Amini, Patriss Moradi, Sudharani Nagaraju, Dvora Bauman, David Shveiky, Shay Porat, Uri Dior, Gurion Rivkin, Omer Or, Nir Hirshoren, Einat Carmon, Alon Pikarsky, Abed Khalaileh, Gideon Zamir, Ronit Grinbaum, Machmud Abu Gazala, Ido Mizrahi, Noam Shussman, Amit Korach, Ori Wald, Uzi Izhar, Eldad Erez, Vladimir Yutkin, Yaacov Samet, Devorah Rotnemer Golinkin, Kirsty L. Spalding, Henrik Druid, Peter Arner, A. M. James Shapiro, Markus Grompe, Alex Aravanis, Oliver Venn, Arash Jamshidi, Ruth Shemer, Yuval Dor, Benjamin Glaser, Tommy Kaplan

Summary: DNA methylation is an important epigenetic mark that regulates gene expression and chromatin organization. This study presents a human methylome atlas based on deep whole-genome bisulfite sequencing, providing a comprehensive analysis of 39 cell types from 205 healthy tissue samples. The atlas reveals tissue-specific methylation patterns and potential biomarkers for liquid biopsies.

NATURE (2023)

Article Genetics & Heredity

TGFβ pathway is required for viable gestation of Fanconi anemia embryos

Alfredo Rodriguez, Michael Epperly, Jessica Filiatrault, Martha Velazquez, Chunyu Yang, Kelsey McQueen, Larissa A. Sambel, Huy Nguyen, Divya Ramalingam Iyer, Ulises Juarez, Cecilia Ayala-Zambrano, David B. Martignetti, Sara Frias, Renee Fisher, Kalindi Parmar, Joel S. Greenberger, Alan D. D'Andrea

Summary: Overexpression of the TGF beta pathway impairs the proliferation of hematopoietic stem and progenitor cells in Fanconi anemia. Genetic disruption of Smad3, a transducer of the canonical TGF beta pathway, modifies the phenotype of Fancd2-deficient mouse models, leading to high levels of embryonic lethality. The activation of the non-canonical TGF beta-ERK pathway is critical for the survival of Fancd2-Smad3 double knockout mice, but it also results in enhanced genomic instability and ineffective hematopoiesis.

PLOS GENETICS (2022)

Article Biology

A Boolean network model of the double-strand break repair pathway choice

Cecilia Ayala-Zambrano, Mariana Yuste, Sara Frias, Benilde Garcia-de-Teresa, Luis Mendoza, Eugenio Azpeitia, Alfredo Rodriguez, Leda Torres

Summary: Double strand break (DSB) repair is crucial for maintaining genome integrity and deficiency in DSB repair can lead to various pathologies. There are different pathways involved in DSB repair, including homologous recombination (HR), non-homologous end joining (NHEJ), microhomology-mediated end-joining (MMEJ), and single-strand annealing (SSA). Epigenetic modifications of histones also play a role in regulating the choice of DSB repair pathway. A Boolean network model was developed to simulate and predict the response of DSB repair pathways, and experimental validation confirmed the predictions.

JOURNAL OF THEORETICAL BIOLOGY (2023)

Meeting Abstract Oncology

STING AGONISM OVERCOMES STAT3-MEDIATED IMMUNOSUPPRESSION AND ADAPTIVE RESISTANCE TO PARP INHIBITION IN OVARIAN CANCER

Liya Ding, Qiwei Wang, Antons Martincuks, Michael Kearns, Tao Jiang, Ziying Lin, Xin Cheng, Changli Qian, Hye-Jung Kim, Inga-Maria Launonen, Anniina Farkkila, Thomas Roberts, Joyce Liu, Panagiotis Konstantinopoulos, Ursula Matulonis, Hua Yu, Jean Zhao

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Meeting Abstract Environmental Sciences

Ovarian Cancer as a Disease of DNA Repair

Liisa Kauppi, Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Taru Muranen, Jaana Oikkonen, Yilin Li, Sampsa Hautaniemi, Fernando Perez, Anniina Farkkila, Johanna Hynninen, Sakari Hietanen, Olli Carpen

ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2022)

Article Pediatrics

Dysmorphology as a Clinical Tool for an Early Diagnosis of Fanconi Anemia

Moises O. Fiesco-Roa, Paulina G. Gomez-Moreno, Rubi M. Espinosa-Curiel, Alfredo Rodriguez, Sara Frias

ACTA PEDIATRICA DE MEXICO (2022)

Article Pediatrics

Fanconi anemia, Part 1. Cytogenetic diagnosis

Bertha Molina, Sandra Ramos, Sara Frias

Summary: Fanconi anemia is a rare disease that requires accurate diagnosis for appropriate management and counseling. The gold standard for diagnosis is the chromosomal aberration test, which can be performed in various tissues. Diagnosis and chromosome analysis require tightly controlled interpretation by highly specialized personnel.

ACTA PEDIATRICA DE MEXICO (2022)

暂无数据